News Breaks |
|
|
| February 14, 2013 |
| 07:36 EDT |  | NPSP, ANTH, VSTM, AGN, THRX, THOR, EXAS | Leerink to host a conference
Global Healthcare Conference 2013 is being held in New York on February 13-14 with webcasted company presentations to begin on February 14 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
|
News For NPSP;ANTH;VSTM;AGN;THRX;THOR;EXAS From The Last 14 Days Check below for free stories on NPSP;ANTH;VSTM;AGN;THRX;THOR;EXAS the last two weeks. |
|
|
| May 22, 2013 |
| 10:14 EDT | | VSTM | Verastem management to meet with Guggenheim
Meetings to be held on the West Coast May 23-24 hosted by Guggenheim. |
|
| 07:28 EDT | | VSTM | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| May 21, 2013 |
| 17:59 EDT |  | NPSP | NPS Pharmaceuticals 6M share Secondary priced at $14.53
 Subscribe for More Information |
|
| 07:44 EDT | | VSTM | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:34 EDT | | NPSP | UBS to host a conference
Subscribe for More Information |
|
| 07:07 EDT |  | THRX | Theravance pullback on Elan bid a buying opportunity, says Piper Jaffray
Subscribe for More Information |
|
| May 20, 2013 |
| 16:22 EDT | | NPSP | NPS Pharmaceuticals files to sell 6M shares of common stock
J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the proposed offering. |
|
| 10:11 EDT |  | THOR | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Artisan Partners (APAM) downgraded to Market Perform from Outperform at Keefe Bruyette... Bank of America (BAC) downgraded to Market Perform from Outperform at Keefe Bruyette... Bed Bath & Beyond (BBBY) downgraded to Hold from Buy at Jefferies... BlackRock (BLK) downgraded to Market Perform from Outperform at Keefe Bruyette... Cavium (CAVM) downgraded to Market Perform from Outperform at JMP Securities... Charles Schwab (SCHW) downgraded to Underperform from Market Perform at Keefe Bruyette... Dunkin' Brands (DNKN) downgraded to Neutral from Buy at Longbow... Equifax (EFX) downgraded to Neutral from Buy at Goldman... Leap Wireless (LEAP) downgraded to Sell from Hold at Deutsche Bank... Lowe's (LOW) downgraded to Perform from Outperform at Oppenheimer... MicroStrategy (MSTR) downgraded to Market Perform from Outperform at JMP Securities... NetApp (NTAP) downgraded to Underperform from Neutral at RW Baird... NeuStar (NSR) downgraded to Neutral from Buy at Goldman... Red Hat (RHT) downgraded to Market Perform from Outperform at BMO Capital... Ruby Tuesday (RT) downgraded to Market Perform from Outperform at Wells Fargo... Synovus (SNV) downgraded to Sell from Neutral at Goldman... TD Ameritrade (AMTD) downgraded to Underperform from Market Perform at Keefe Bruyette... Thoratec (THOR) downgraded to Neutral from Buy at Goldman... CF Industries (CF) downgraded to Hold from Buy at Miller Tabak... Children's Place (PLCE) downgraded at Susquehanna... CarMax (KMX) downgraded to Market Perform from Outperform at William Blair... SanDisk (SNDK) downgraded to Neutral from Buy at Nomura... Red Hat (RHT) downgraded at BMO Capital... Rex Energy (REXX) downgraded to Hold from Buy at Stifel... Range Resources (RRC) downgraded to Hold from Buy at Stifel... Kansas City Southern (KSU) downgraded to Sell from Hold at Stifel... Capella Education (CPLA) downgraded to Hold from Buy at Stifel. |
|
| 06:06 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Goldman
Subscribe for More Information |
|
| May 17, 2013 |
| 08:04 EDT |  | THOR | Thoratec announces FDA approval of HeartMate II Pocket Controller
Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. |
| |
| May 16, 2013 |
| 11:27 EDT |  | THRX | Options with decreasing implied volatility: LNCO MBI OPK THRX SGMO
Subscribe for More Information |
|
| May 15, 2013 |
| 11:13 EDT | | THRX | Options with decreasing implied volatility: MM GMCR GRPN THRX SGMO
Subscribe for More Information |
|
| May 14, 2013 |
| 12:16 EDT | | THRX | Options with decreasing implied volatility: MM PANL DGIT VCLK THRX
Subscribe for More Information |
|
| 08:16 EDT | | THRX | Theravance price target raised to $48 from $38 at RW Baird
Subscribe for More Information |
|
| 07:18 EDT | | AGN | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
| 07:07 EDT | | THRX | Theravance price target raised to $54 from $44 at Stifel
Stifel thinks that Theravance's (THRX) royalty deal with Elan (ELN) demonstrates its ability to generate revenue that had not been reflected in its stock price. The firm expects Theravance to make similar deals in the future and it keeps a Buy rating on the stock. |
|
| 07:04 EDT | | VSTM | Verastem appoints Jack Green as CFO
Subscribe for More Information |
|
| May 13, 2013 |
| 17:25 EDT |  | ANTH | Anthera Pharmaceuticals reports Q1 EPS (6c), consensus (9c)
Subscribe for More Information |
|
| 16:25 EDT |  | THRX | On The Fly: Closing Wrap
Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. |
|
| 12:20 EDT | | THRX | On The Fly: Midday Wrap
Subscribe for More Information |
| |
|
|
|
|
